The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Stakhovskaya L.V.

Pirogov Russian National Research Medical University, Moscow, Russia

Tyutyumova E.A.

Pirogov Russian National Research Medical University

Fedin A.I.

Kafedra nevrologii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Modern approaches to neuroprotective treatment of ischemic stroke

Authors:

Stakhovskaya L.V., Tyutyumova E.A., Fedin A.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(8‑2): 75‑80

DOI: 10.17116/jnevro20171178275-80

Views: 758

Downloaded: 26

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Stakhovskaya LV, Tyutyumova EA, Fedin AI. Modern approaches to neuroprotective treatment of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(8‑2):75‑80. (In Russ.)
https://doi.org/10.17116/jnevro20171178275-80

Подписка 2025 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Close metadata
Recommended articles:
Expe­rience of clinical use of fluvoxamine for the treatment of como­rbid depression in childhood and adolescence. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(11-2):14-21
Sexual dysfunction on the background of anti­depressant therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(11-2):115-121
Reve­rsible cere­bral vaso­constriction syndrome and ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12-2):17-23
New data on the pathophysiology of ischemic stroke: epigenetic mechanisms in focus. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12-2):24-29
Craniocerebral hypo­thermia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12-2):43-48
The impact of therapy with Mexi­dol on neurological defi­cit and functional outcome in patients with ischemic stroke: a systematic review and meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12-2):49-60
The effect of reha­bilitation with sensory glove and virtual reality on concentration of brain-derived neurotrophic factor and event rela­ted pote­ntial P300 in the early reha­bilitation period after ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12-2):75-81
The effect of mexi­dol as part of complex therapy on the perception of life in patients with heart failure. Russian Journal of Cardiology and Cardiovascular Surgery. 2023;(6):642-652
Bullet embo­lism of inte­rnal caro­tid artery. (A case report and lite­rature review). Burdenko's Journal of Neurosurgery. 2023;(6):85-92
Pseudotumorous form of primary central nervous system vasculitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12):141-147

The authors present the results of domestic clinical trials on the efficacy and safety of mexidol in patients with cerebrovascular disorders including ischemic stroke (IS). The use of mexidol is associated with complete and rapid regression of the focal neurological deficit. Mexidol is well tolerated with no significant side-effects. The drug is recommended for enteral and parenteral administration in patients with IS.

Keywords:

ischemic stroke
treatment
mexidol

Authors:

Stakhovskaya L.V.

Pirogov Russian National Research Medical University, Moscow, Russia

Tyutyumova E.A.

Pirogov Russian National Research Medical University

Fedin A.I.

Kafedra nevrologii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

List of references:

  1. Ivanova GE, Shklovskii VM, Petrova EA. The principles of early rehabilitation of stroke patients. Kachestvo zhizni. Meditsina. 2006;2(13):62-70. (In Russ.).
  2. Skvortsova VI. Snizhenie zabolevaemosti, smertnosti i invalidnosti ot insul’tov v Rossiiskoi Federatsii. M.: Litterra; 2008. (In Russ.).
  3. Fedin AI, Tyutyumova EA, Badalyan KR. Ischemic cascade in the acute period of the stroke and methods of its correction. Farmateka. 2017;9:99-104. (In Russ.).
  4. Khasanova DR, Gavrilov IA, Prokof’eva IuV, Kamalov IR. The introduction of the multilevel system of medical care for stroke patients in the Tatarstan Republic. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2014;114:8(2):74-79. (In Russ.).
  5. Fedin AI. Klinicheskie aspekty patogeneticheskoi terapii ishemii golovnogo mozga. Minimizatsiya negativnogo prognoza. M.: OOO «AST»; 2016. (In Russ.).
  6. Voronina TA. The pioneer of antioxidant neuroprotection. 20 years in clinical practice. RMJ. 2016;24(7):434-438. (In Russ.).
  7. Shulkin AV. Mexidol influence on the development of the phenomen of neurons excitotoxicity in vitro. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112(2):35-39. (In Russ.).
  8. Skvortsova VI, Stakhovskaya LV, Nartsyssov YaR, Bodykhov MK, Kichuck IV, Gudkova YuV, Soldatenkova TD, Kondrasheva TT, Kalinina EV, Novichkova MD, Kerbikov OB. The randomized double-blind placebo-controlled study of efficacy and safety of mexidol in the complex therapy of ischemic stroke in the acute period. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2006;106(18):47-54. (In Russ.).
  9. Novikova LB, Sharafutdinova LR, Sharapova KM. The use of mexidol in acute period of ischemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;113:9:83-85. (In Russ.).
  10. Shchepankevich LA, Nicolaev YuA, Dolgova NA, Chipova DT. Optimization of hypolipidemic therapy in patients with ischemic stroke and diabetes mellitus. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2016;116:2:42-45. (In Russ.).
  11. Odinak MM, Ianishevskiĭ SN, Tsygan NV, Golokhvastov SIu, Vozniuk IA, Trufanov AG. The use of succinates for the correction of metabolic disorders in the penumbra in patients with stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;113:12(2):12-17. (In Russ.).
  12. Chefranova ZhYu, Makotrova TA, Udachin VA, Koledintseva EV. Efficacy of mexidol in the combination with thrombolytic therapy in patients with ischemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112:4:49-52. (In Russ.).
  13. Stakhovskaya LV, Shamalov NA, Khasanova DR, Melnikova EV, Agafiina AS, Golikov KV, Bogdanov EI, Yakupova AA, Roshkovskaya LV, Lukinykh LV, Lokshtanova TM, Poverennova IE, Shepankevich LA. Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2017;117:3(2):55-65. (In Russ.). https://doi.org/10.17116/jnevro20171173255-65

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.